Indian Pharma Market sees significant revival in March 2021, registers 10.3 percent growth: AIOCD-AWACS Report Medical Dialogues Team25 April 2021 11:45 AM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has witnessed a significant revival with a rise of 10.3 per cent for the month of March 2021,...
Zydus Cadila gets DCGI nod to moderate Covid-19 drug Virafin Ruchika Sharma24 April 2021 1:06 PM ISTVirafin will be available on the prescription of medical specialist for use in hospital/ institutional setup.
Zydus Cadila bags USFDA nod for anti-arrhythmic drug Propafenone Hydrochloride ER Capsules Ruchika Sharma23 April 2021 10:00 AM ISTAhmedabad: Drug major, Zydus Cadila, has recently announced that the company has received final approval from the United States Food and Drug...
India to have 5 more COVID vaccines by Oct Ruchika Sharma12 April 2021 12:02 PM ISTThese vaccines are Sputnik V vaccine, Johnson and Johnson vaccine, Novavax vaccine, Zydus Cadila's vaccine, and Bharat Biotech's Intranasal Vaccine.
Govt directs Sun Pharma, Cipla, 5 others to ramp up Covid drug remdesivir production to full capacity Ruchika Sharma8 April 2021 5:03 PM ISTMandaviya said these seven manufacturers- Mylan, Hetero, Jubiliant Life Sciences, Cipla, Dr Reddy''s, Zydus Cadila and Sun Pharma - have a monthly...
Zydus Macitentan gets USFDA okay, eligible for 180 days of shared generic drug exclusivity Ruchika Sharma8 April 2021 12:20 PM ISTAhmedabad: Pharma major, Zydus Cadila, today announced that the company has received final approval from the United States Food and Drug...
Zydus Cadila cancer drug Ibrutinib secures USFDA nod Ruchika Sharma8 April 2021 11:30 AM ISTFor Ibrutinib Capsules, 140 mg, the company will have 180-days of shared generic drug exclusivity.
COVID-19: Zydus Cadila seeks DCGI nod for Pegylated Interferon alpha-2b Medical Dialogues Bureau5 April 2021 11:24 AM ISTAhmedabad: Drugmaker, Zydus Cadila, announced that its Phase III clinical trials with Pegylated Interferon Alpha 2b, PegiHep has shown promising...
Zydus, Alembic Pharma recall drugs in US over life-threatening consequences Ruchika Sharma31 March 2021 11:58 AM ISTNew Delhi: US-based arms of domestic pharma firms Zydus Cadila and Alembic Pharmaceuticals are recalling one drug each in the US after receiving...
Zydus Cadila gets tentative USFDA nod for cocktail drug Emtricitabine, Tenofovir Disoproxil Fumarate to treat HIV Ruchika Sharma26 March 2021 11:00 AM ISTAhmedabad: Drugmaker, Zydus Cadila, has recently announced that the company has received tentative approval from the United States Food and...
Cadila Healthcare Settles Patent Litigation for Generic Revlimid in US Medical Dialogues Team25 March 2021 5:15 PM ISTNew Delhi: Drugmaker Cadila Healthcare Limited and its subsidiary Zydus Pharmaceuticals (USA) Inc. (Zydus Cadila) have recently announced that they...
Zydus reduces COVID-19 drug Remdesivir price to Rs 899 Ruchika Sharma25 March 2021 1:51 PM ISTAhmedabad: In a significant move Zydus has made its brand of Remdesivir, Remdac more affordable at Rs. 899 for a 100 mg lyophilized injection....
